Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Interferon Type I
81%
Interferon
68%
Non-Alcoholic Fatty Liver Disease
47%
Omicron Coronavirus Variant
45%
Viral Disease
44%
Hepatitis C Virus
37%
Steatohepatitis
31%
Alveolar Macrophage
27%
Immune Evasion
25%
Adaptive Immune System
25%
Neutralizing Antibody
22%
Vaccine Efficacy
22%
Viral Entry
22%
Glucose 6 Phosphate Isomerase
22%
Therapeutic Antibodies
22%
Hemophagocytic Lymphohistiocytosis
22%
Varicella Zoster Virus
22%
Promoter Region
18%
Genetic Variation
17%
Cytotoxic T-Cell
15%
COVID-19
13%
Single Nucleotide Polymorphism
13%
Spike
11%
Vaccination Policy
9%
Cytokine
8%
Respiratory Virus
8%
Chickenpox
8%
Monospecific Antibody
7%
Virus Evolution
7%
Genetic Polymorphism
7%
Infectious Disease
7%
Viral Clearance
7%
Haplotype
6%
Interferon Production
6%
Interferon Type III
6%
Herpes Zoster
5%
Peripheral Blood Mononuclear Cell
5%
Pneumonitis
5%
Sendai Virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
45%
Nonalcoholic Fatty Liver
45%
Interferon
45%
Virus Fusion Inhibitor
22%
Neutralizing Antibody
22%
Fibrosis
15%
Infection
9%
Vaccination Policy
9%
Liver Fibrosis
7%
Hepatitis
5%
Neuroscience
Hepatitis C Virus
32%
SARS Coronavirus
30%
Interferon
30%
Genetic Variation
17%
T Cell
15%
CD8
15%
Genetic Polymorphism
7%
Genome Project
7%
Haplotype
5%
